US President Trump prohibits federal funding for COVID-19 vaccine mandates in schools
The Order bars federal funds from being used to support or subsidize an educational service agency, state education agency, local…
Transparency of vaccine purchases: Order of the EU Court’s Vice-President in Case C-632/24 P(R)
The EU Commission’s obligation to disclose the identity of the members of the negotiating team for the advance purchase of…
EU Commission extends authorisation of Mpox vaccine to adolescents
The EU Commission has extended the authorisation of the Imvanex vaccine to adolescents aged 12 to 17 years. Imvanex is…
Europe’s Beating Cancer Plan: EU advances vaccines preventing cancers
The EU Council has adopted a recommendation that aims to combat vaccine-preventable cancers in the EU by boosting the uptake of vaccinations…
Avian flu: EU Commission secures access to vaccines for EU Member States
The EU Commission's Health Emergency Preparedness and Response Authority (HERA) has signed a joint procurement framework contract for the supply…
Finland: More healthcare professionals would be allowed to administer vaccines
The aim is to accelerate and streamline the administration of vaccines and to alleviate the shortage of healthcare personnel. The…
European Immunization Week 2023: Joint statement by EU Commissioner Kyriakides, the WHO and UNICEF
Brussels, 24 April 2023 European Immunization Week 2023 and beyond: catching up and moving towards...
COVID-19: EP mission assesses work of EMA and BioNTech
Brussels, 21 September 2022 On 20-21 September, a delegation of the special committee on COVID-19...
ECDC and EMA recommendations on use of adapted COVID-19 vaccines
Solna, 6 September 2022 The European Centre for Disease Prevention and Control (ECDC) and the...
COVID-19: EU Commission proposes concrete measures to prepare for autumn and winter
Brussels, 2 September 2022 Today, the Commission is proposing concrete measures to avoid a surge of...
COVID-19: MEP’s debate with the pharmaceutical industry
MEPs will talk with representatives from pharmaceutical companies that worked on developing vaccines and therapeutics...
COVID-19: Stella Kyriakides on the first variant-adapted booster vaccines
Brussels, 1 September 2022 Today, the European Medicines Agency (EMA) has given a positive opinion...
Transparency and ethics: text message exchange between Ursula von der Leyen and Pfizer CEO – EU Commission answer
Brussels, 17 August 2022 See question(s) : E-000382/2022 EN E-000382/2022 Answer given by Vice-President Jourová on...
EU Commission and Moderna adapt vaccines delivery for late summer and winter
Brussels, 9 August 2022 The European Commission and Moderna have reached an agreement to better...
COVID-19 vaccines: ECDC and EMA update recommendations on booster doses
11 Jul 2022 The European Centre for Disease Prevention and Control (ECDC) and the European...
The G20, public goods, and global commons – EEAS Blog post by EU HR Borrell
07.07.2022 HR/VP Blog – The world has been struggling with ‘war, famine and pestilence’ and...
EU Commission: Start of vaccines delivery in response to monkeypox outbreak
Brussels, 28 June 2022 Today, the delivery of the first vaccine doses purchased by the European Commission’s...
HERA secures monkeypox vaccines for EU Member states
Brussels, 14 June 2022 Today, HERA, the European Commission’s Health Preparedness and Response Authority, concluded...
Africa: EU and WHO want to boost local medicine manufacturing
Brussels, 24 March 2022 EU strengthens partnership with WHO to boost local manufacturing and access...
EU Health Ministers discuss 4th vaccine shot and COVID-19 crisis management
20 January 2022 The European health ministers will meet this Friday, 21 January 2022, via...
Bundesrat bestätigt neue Vorgaben für Impfnachweise und Quarantäneregeln
Berlin, 14 Januar 2022 Eine Änderungsverordnung der Bundesregierung passt die Vorgaben für Impf- und Genesenennachweise...
ECDC update: Omicron variant of concern (VOC) as of 13 January 2022
Stockholm, 14 January 2022 From 20 December 2021 to 2 January 2022, there were 21...
EMA: Global regulators discuss regulatory alignment on Omicron variant response
13/01/2022 On 12 January, regulators from around the world discussed the global regulatory response to...
EU Commission authorises Nuvaxovid as 5th vaccine against COVID-19
Brussels, 20 December 2021 Today, the European Commission has granted a conditional marketing authorisation (CMA)...
EMA starts rolling review of Valneva’s COVID-19 vaccine (VLA2001)
News 02/12/2021 EMA’s human medicines committee (CHMP) has started a rolling review of VLA2001, a...
COVID-19 medicines: EU Commission hosts 2nd event to speed up development and production
Today and tomorrow, the Commission is hosting a pan-European matchmaking event to accelerate and upscale...
EMA: Executive Director to update MEPs on COVID-19 vaccines and treatments
MEPs will quiz EMA Executive Director Emer Cooke on the latest developments regarding COVID-19 vaccines...
Renew Europe: EU Commission should use extra budget to help vaccinate the Worldlivery
NOVEMBER 24, 2021 While the EU faces a new COVID-19 wave, we are reminded that...
EU COVID-19 vaccine strategy: EU Commission approves contract with Valneva
Brussels, 10 November 2021 Today, the European Commission approved the eighth contract with a pharmaceutical...
S&Ds: The EU must honour its vaccine pledge for Africa and developing countries
No one is safe until everyone is safe. This was supposed to be the lesson...
United States and EU launch joint “COVID-19 Manufacturing and Supply Chain Taskforce”
Brussels, 22 September 2021 Ending the COVID-19 pandemic through global cooperation remains our first priority....
Beating the Pandemic – Joint EU-US statement on vaccines, therapeutics, and health security
New York, 22 September 2021 Vaccination is the most effective response to the COVID pandemic....
AstraZeneca on reaching EU settlement agreement over vaccine supply
3 September 2021 09:00 BST AstraZeneca and the European Commission have reached an agreement that...
EU Commission Q&A on AstraZeneca’s COVID-19 vaccine supply and litigation
Brussels, 3 September 2021 How does the settlement agreement compare in terms of quantity of...
EU Commission and AstraZeneca agree on COVID-19 vaccine supply, ending litigation
3 September 2021 Today the EU and AstraZeneca have reached an agreement which will secure...
Purchase of the Russian vaccine ‘Sputnik V’ by the regional government of Madrid without prior centralised authorisation from the EMA – EU Commission answer
Answer given by Ms Kyriakides on behalf of the European Commission (27.8.2021) 1. By concluding...
Multilateral Leaders Taskforce on Scaling COVID-19 Tools: A Crisis of Vaccine Inequity
August 27, 2021 Geneva / Washington, DC: At its third meeting, the Multilateral Leaders Taskforce on...
COVID-19 vaccines: Interactive map on vaccine production capacities in the EU
Today, the Commission published an interactive map showcasing COVID-19 vaccine production capacities in the EU, along the...
Coronavirus: EU Civil Protection Mechanism shares 3 million vaccines doses
Following new offers of assistance from EU Member States to countries in need, the Commission...
We need to do more on the vaccine divide – Blog post by EU High Commissioner Borrell
13/07/2021 – HR/VP Blog – While vaccination rates are rising rapidly in Europe, this is not...
EU Commission President von der Leyen: Vaccine deliveries to vaccinate 70% of EU adults
I have good news for our European citizens today. The EU has kept its word....
Senegal: “Team Europe” and other partners build a vaccine manufacturing plant
Brussels, 9 July 2021 President of the Republic of Senegal, His Excellency Macky Sall, welcomes...
COVID-19 Vaccines Task Force for Developing Countries: Joint Statement by World Bank, IMF, WHO, and WTO
June 30, 2021 WASHINGTON, DC: The Heads of the World Bank Group, International Monetary Fund, World...
ECDC report counters “online vaccine misinformation in the EU/EEA”
On June 29, the European Centre for Disease Prevention and Control (ECDC) published the report...
ECDC update on the spread of the Delta variant for the EU and EEA
ECDC publishes a threat assessment brief on the implications of the spread of the Delta variant of...
EU Commission activates purchase of 150m optional Moderna vaccine doses in 2022
Today, the European Commission approved the amendment to the second contract with the pharmaceutical company...
EU Commission Q&A on Belgian Court orders concerning AstraZeneca’ vaccine deliveries
Brussels, 19 June 2021 Why did the European Commission start this Court proceeding and what...
Interim measures: Belgian Court orders AstraZeneca to deliver vaccine doses to the EU
Brussels, 18 June 2021 Today, the Court of First Instance of Brussels decided to...
ECDC updates COVID-19 Rapid Risk Assessment for EU/EEA (circulation, variants, non-pharmaceutical interventions and vaccine rollout)
ECDC has published a new COVID-19 Rapid Risk Assessment titled Assessing SARS-CoV-2 circulation, variants of concern,...
EU Parliament calls for COVID-19 vaccine patent waiver
Patent waiver will enhance global access to affordable COVID-19 vaccines Voluntary licensing, transfer of know-how...